Boston Scientific Corporation (BSX) Stock Analysis

Boston Scientific Corporation (BSX) Stock Analysis — AI Research | MarketCI

BSX

Market Closed

Boston Scientific Corporation

NYSEHealthcare Medical - Devices

53.00K employees

CEO: Michael F. Mahoney

Founded: 1992

$45.29

+$0.00(+NaN%)

Market Cap

67.32B

Beta

0.56

52W Range

N/A

Dividend Yield

0.00%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

BSX Price Chart

Historical price performance

Loading MCI price data...

MarketCI Investment Signals

AI-synthesized investment signal for BSX built from valuation, fundamentals, sentiment, and risk models

Investment Signal

Hold

Pass %

57.14%

Score

4/7

Fair Value Estimate

Cash flow analysis • Multiple methods

$112.43

AI Price Target

Machine learning • Price prediction

$37.79

Market Sentiment

News & social media analysis

0.23

Value Investor Price

Classic value analysis

$18.78

Financial Health

Bankruptcy risk assessment

3.73

Quality Score

Financial strength rating

7.00

AI Investment Grade

Deep analysis of filings & news

62.00

Key Investment Highlights

Important factors affecting BSX investment thesis

Due Diligence Analysis

Investment criteria assessment and scoring

Overall Assessment

67.50% Good

Conditions Met

27.00/40.00

Due Diligence Score

67.50%

Due Diligence Conditions

Investment analysis conditions and results


	Pass
	Fail
	Pass
	Fail
	Pass
	Pass

Showing 1 to 6 of 46 conditions